This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Service, F. J. Articles by O’Brien, P. C. Search for Related Content PubMed PubMed Citation Articles by Service, F. J. Articles by O’Brien, P. C. Related Collections Endocrine Oncology Metabolism

Increasing Serum Betahydroxybutyrate Concentrations during the 72-Hour Fast: Evidence against Hyperinsulinemic Hypoglycemia

Division of Endocrinology, Metabolism and Nutrition (F.J.S.) and Department of Biostatistics (P.C.O.), Mayo Clinic, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: F. John Service, M.D., Ph.D., Mayo Clinic, Division of Endocrinology, Metabolism and Nutrition, 200 First Street SW, Rochester, Minnesota 55905. E-mail: service.john{at}mayo.edu.

Objective: We have determined whether the behavior of betahydroxybutyrate (BOHB) during the 72-h fast of persons without evidence of hyperinsulinemic or any form of organic hypoglycemia might provide indicators of a negative fast.

Design: Twenty-one patients with surgically confirmed insulinoma and 34 patients with negative 72-h fasts had BOHB measured every 6 h until Whipple’s triad in the former and until 72-h in the latter.

Results: Quadratic regression curves of BOHB from the negative fasts showed the typical curve to be flat initially, then increase in a manner that was roughly linear. Using time-specific medians, the changes were: 12–18 h, 0% increase; 18–36 h, 333% increase; 36–54 h, 210% increase, and 54–72 h, 167% increase. In contrast, patients with insulinoma had suppressed BOHB concentrations. Two successive BOHB values in excess of the 18-h level seemed to portend a negative fast. By using the previously published criterion of BOHB more than 2.7 mmol/liter (a surrogate for hypoinsulinemia and thereby an indicator of a negative fast), 74% of persons with a negative fast reached this level before the 72-h point.

Conclusions: Serial measurements of BOHB during the 72-h fast have the potential to provide not only clues during the fast that it will ultimately be negative, but also the opportunity to truncate the fast if the endpoint BOHB criterion for a negative fast is met before 72 h.

This article has been cited by other articles:

				P. E. Cryer, L. Axelrod, A. B. Grossman, S. R. Heller, V. M. Montori, E. R. Seaquist, and F. J. Service Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 709 - 728. [Abstract] [Full Text] [PDF]

				D Vezzosi, A Bennet, J Fauvel, and P Caron Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism Eur. J. Endocrinol., July 1, 2007; 157(1): 75 - 83. [Abstract] [Full Text] [PDF]

				P. Kar, P. Price, S. Sawers, S. Bhattacharya, R. H. Reznek, and A. B. Grossman Insulinomas May Present with Normoglycemia after Prolonged Fasting but Glucose-Stimulated Hypoglycemia J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4733 - 4736. [Abstract] [Full Text] [PDF]

				T.-K. Khoo and F. J. Service 47-Year-Old Woman With Spells of Slurred Speech, Blurred Vision, and Loss of Consciousness Mayo Clin. Proc., November 1, 2006; 81(11): 1495 - 1498. [Full Text] [PDF]